➤ Subscribe for Complete Access

Flexible subscription options to meet your unique needs…

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Harvard Business School
McKinsey
Medtronic
Dow

Last Updated: November 27, 2021

DrugPatentWatch Database Preview

Patent: 10,421,809

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 10,421,809
Title:Anti-TLR4 antibodies and uses thereof
Abstract: This invention relates generally to antibodies that specifically bind Toll-like Receptor 4 (TLR-4), and to methods of using the anti-TLR4 antibodies as therapeutics and to methods of using the anti-TLR4 antibodies in methods of preventing transplant rejection and/or prolonging survival of transplanted biological material.
Inventor(s): Kosco-Vilbois; Marie (Minzier, FR), De Graaf; Katrien (Nyon, CH), Berney; Thierry (Arenthon, FR), Santa Giovannoni; Laurianne (Annemasse, FR), Bosco; Domenic (Geneva, CH)
Assignee: NovImmune SA (Geneva, CH)
Application Number:15/370,466
Patent Claims:see list of patent claims

Details for Patent 10,421,809

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Janssen Biotech, Inc. REMICADE infliximab For Injection 103772 1998-08-24 ⤷  Try it Free 2031-01-10
Immunex Corporation ENBREL etanercept For Injection 103795 1998-11-02 ⤷  Try it Free 2031-01-10
Immunex Corporation ENBREL etanercept For Injection 103795 1999-05-27 ⤷  Try it Free 2031-01-10
Immunex Corporation ENBREL etanercept Injection 103795 2004-09-27 ⤷  Try it Free 2031-01-10
Immunex Corporation ENBREL etanercept Injection 103795 2007-02-01 ⤷  Try it Free 2031-01-10
Immunex Corporation ENBREL MINI etanercept Injection 103795 2017-09-14 ⤷  Try it Free 2031-01-10
Immunex Corporation ENBREL etanercept Injection 103795 ⤷  Try it Free 2031-01-10
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Medtronic
Dow
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.